1 / 38

Common Respiratory Disorders of the Neonate

Common Respiratory Disorders of the Neonate. Common Pulmonary Causes of Respiratory Distress in Neonates. Parenchymal conditions ● Transient tachypnea of the newborn ● Meconium aspiration syndrome and other aspirations ● Respiratory distress syndrome ● Pneumonia ● Pulmonary edema

damatoj
Download Presentation

Common Respiratory Disorders of the Neonate

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Common Respiratory Disorders of the Neonate

  2. Common Pulmonary Causes of Respiratory Distress in Neonates Parenchymal conditions ● Transient tachypnea of the newborn ● Meconium aspiration syndrome and other aspirations ● Respiratory distress syndrome ● Pneumonia ● Pulmonary edema ● Pulmonary hemorrhage ● Pulmonary lymphangiectasia Developmental abnormalities ● Lobar emphysema ● Pulmonary sequestration ● Cystic adenomatoid malformation ● Congenital diaphragmatic hernia ● Tracheoesophageal fistula ● Pulmonary hypoplasia Airway abnormalities ● Choanal atresia/stenosis ● Laryngeal web ● Laryngotracheomalacia or bronchomalacia ● Subglottic stenosis Mechanical abnormalities ● Rib cage anomalies (eg, Jeune syndrome) ● Pneumothorax ● Pneumomediastinum ● Pleural effusion ● Chylothorax

  3. The Neonatal Lung is a Work in Progress • Canalicular phase • Saccular phase • Alveolar phase Agrons Radiographics 2005

  4. Respiratory Distress Syndrome(Hyaline Membrane Disease) • Definition? • 1960 – clinical definition describing respiratory distress and a hyaline membrane lining dilated terminal airspaces • 2006 – clinical definition describing respiratory distress and x-ray findings • There is no “test” for RDS

  5. Surfactant is Amazing A mixture of lipid and protein that lowers surface tension on an air-water interface Jobe NeoReviews 2006

  6. A Very Complex Metabolism • Surfactant is made in type II cells, works in the fluid hypophase of the alveoli and is recycled Jobe NeoReviews 2005

  7. RDS is Inversely Related to Gestational Age • Incidence in 2006 • 501-1500g (42%) • 501 -750g (71%) • 751-1000g (54%) • 1001-1250g (36%) • 1251-1500g (22%) • More common in males than females Fanaroff and Martin 2006 p1098

  8. Surfactant Maturation Can Be Accelerated • Corticosteroids • TRH • Inflammation • Heroin

  9. Pathophysiology is Less Complicated Than It Looks Fanaroff and Martin 2006 p 1100

  10. Pathophysiology is Less Complicated Than It Looks Fanaroff and Martin 2006 p 1100

  11. Clinical Manifestations • Symptoms usually within hours of birth • Non-specific: tachypnea, cyanosis, nasal flaring, grunting, retractions, etc • Progressive worsening over 2-3 days followed by slow recovery • Classic CXR findings • Diffuse reticulogranular pattern • Air bronchograms

  12. Classic RDS

  13. Management 1960s Style • Supplemental oxygen • High humidity • Antimicrobials • Rocking chair devices • Sternal fixation

  14. Management 2007 Style • Supplemental oxygen and respiratory support • Attention to thermoregulation • Antibiotics • IV fluids • Exogenous surfactant

  15. Exogenous Surfactant • There is no question that it works • Decreases mortality from RDS • +/- decrease in BPD • Surfactant works best when: • Administered shortly after birth • Given rapidly • Followed by distending pressure

  16. Other Surfactant Fun Facts • Components are recycled and “improved” like natural surfactant • May need additional doses • Optimal ventilator strategies following administration are more a matter of opinion than science

  17. Respiratory Support • Goals are to: • Survive the acute phase of the disease • Minimize side effects • Minimize chance of chronic lung disease • Lots of opinion, but no consensus • Conventional ventilation • Pressure • volume • nCPAP • HFV

  18. First Do As Little Harm As Possible Fanaroff and Martin 2006 p 1100

  19. Chronic Lung Disease is Related to Our Treatments Fanaroff and Martin 2006 p 1100

  20. Ventilator Strategies • Distending pressure • Lower Peak Inspiratory Pressures • Lower Tidal Volumes • Early extubation • Permissive hypercarbia • Permissive hypoxemia

  21. Nasal CPAP? • Some places use it exclusively as their first-line mode of respiratory support • Columbia Univ – 76% success in infants with BW < 1250g and 50% with BW < 750g • Requires everyone to buy into the system • Can’t give surfactant unless also intubated • Most places use nCPAP for less severe symptoms, following extubation or in conjunction with “in-and-out” surfactant

  22. High Flow Nasal Cannula • Nasal Cannula at atypical flows (< 1LPM) • Usually 2-8 LPM in our NICU • Used to provide distending pressure in a similar manner as nCPAP • Does not appear to be equal to nCPAP in efficacy • ? Increased respiratory infection rate

  23. Complications of RDS and Its Treatment • Air Leak Syndrome

  24. More Complications • Airway injury • Subglottic stenosis (1% < 1.5kg) • Infection • PDA • IVH • Long-term outcomes • More related to gestational age and BW • Most with normal exercise tolerance

  25. BPD, a Most Troubling Complication • It begins with the definition: • Supplemental oxygen at 28 days of life following oxygen/ventilator therapy in the first week of life • Supplemental oxygen at 36 weeks PMA following oxygen/ventilator therapy in the first week of life • NIH consensus conference 2000

  26. Now It All Makes Sense? The bottom line is that you will see all three definitions

  27. Pathophysiology of BPD • Lungs are attempting to: • Heal • Grow and develop • Respond to continued insults

  28. CLD is Associated With: • Prematurity • Mechanical trauma • Oxygen toxicity • Infection/inflammation • Pulmonary edema • PDA • ? genetics

  29. The Old and the New BPD

  30. Clinical Features • BPD is a systemic disease • Pulmonary • Respiratory distress • Hypoxemia, hypercarbia • Increased airways resistance • Growth deficiency • Developmental delay • Cardiovascular dysfunction • Systemic hypertension, ventricular hypertrophy • Metabolic derangements • Sodium, calcium, etc

  31. Management • Minimize further harm • Permissive hypercapnea. etc. • Aggressive nutritional support • Conservative fluid management • Caution with diuretics • +/- bronchodilators • Steroids with caution • Minimize and aggressively treat infections • Developmental care

  32. Perinatal aspiration of meconium Complicates ~4% of deliveries through meconium stained amniotic fluid Meconium Aspiration Syndrome Fanaroff and Martin 2006 p1123

  33. MAS • Coarse infiltrates • Widespread consolidation • Hyperinflation • Pneumothorax and pneumomediastinum may be present

  34. Management of MAS • Prevention • Supportive respiratory therapy • ? Higher pO2 • Normal pCO2 • Nitric oxide and other PPHN therapies • Antibiotics • surfactant

  35. Transient Tachypnea • Described in the 1960s • Later called RDS Type 2 • Delayed clearance of pulmonary fluid • More common in: • Late preterm • C/S birth • Perinatal depression • Maternal diabetes • Diagnosis of exclusion

  36. Symptoms of TTN • Mild to moderate respiratory distress shortly after birth • Increased central vascular markings ("star-burst") • Evidence of interstitial and pleural fluid • Spontaneous improvement in hours to a few days

  37. Other Aspiration Syndromes • Babies can aspirate blood and amniotic fluid • No specific diagnostic test • May mimic TTN or MAS • Management is the same

More Related